Experts caution retail investors as grey market premiums and easy financing drive over-subscription, distort price discovery

The price band has been fixed at Rs 129-130 per share for the IPO, which will open for public subscription during March 15-17.

Public listings in the latter half of the year gave an average gain of 35 per cent on the first day, besting previous records set in an era...

The IPO is a fresh issuance aggregating to Rs 500 crore and an offer for sale of face value of Rs 2 each by the promoter selling shareholde...

BNP Paribas Arbitrage sold over 5.24 lakh shares of Angel Broking while Alphagrep Securities bought and sold almost the same number of shar...

Vanguard Group bought shares of Can Fin Homes, while Caladium Investment offloaded some of its stake.

Angel Broking IPO was subscribed 3.94 times. You can now check the allotment status.

The events of the recent months prompted the government to roll out an incentive scheme to promote the local production of key active ingre...

“We saw some investors’ reluctance in the Angel Broking IPO. They seem to be getting mindful of the fact that they need to separate the whe...

The Vadodara-based company plans to raise Rs 318 crore, out of which it already raised Rs 95.40 crore through allotment of 28.06 lakh share...

Chart topper Venus Remedies has rallied the most at 546 per cent, followed by Aarti Drugs (up 382 per cent), Mangalam Drugs (375 per cent),...

Chemcon Speciality Chemicals IPO will fetch Rs 318 crore at the upper end of the price band. Bidding closes tomorrow.

Sagar Shah of Ascent Wealth Advisers, an entity that deals in unlisted shares, said Chemcon’s premium in the grey market had risen to Rs 27...

On Friday, the company raised Rs 95.40 crore through allotment of 28.06 lakh shares to anchor investors at Rs 340 per share.

The issue would comprise of fresh issue of equity shares aggregating up to Rs 165 crore and an offer for sale of up to 45,00,000 equity sha...

Nagaraj Shetti, Technical Research Analyst, HDFC Securities, said Nifty may trade rangebound with a negative bias in the short term

All three IPOs are likely to get a good response from the investors following the huge successes of the last three - Rossari Biotech, Happi...